Related references
Note: Only part of the references are listed.Persistent Therapeutic Effect of Repeated Injections of Onabotulinum Toxin A in Refractory Bladder Pain Syndrome/Interstitial Cystitis
Rui Pinto et al.
JOURNAL OF UROLOGY (2013)
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
Victor W. Nitti et al.
JOURNAL OF UROLOGY (2013)
Botulinum Toxin A Detrusor Injections Reduce Postsynaptic Muscular M2, M3, P2X2, and P2X3 Receptors in Children and Adolescents Who Have Neurogenic Detrusor Overactivity: A Single-blind Study
Heinrich Schulte-Baukloh et al.
UROLOGY (2013)
Botulinum Neurotoxin Serotype A Suppresses Neurotransmitter Release from Afferent as Well as Efferent Nerves in the Urinary Bladder
Youko Ikeda et al.
EUROPEAN UROLOGY (2012)
Contemporary Management of the Painful Bladder: A Systematic Review
Antonella Giannantoni et al.
EUROPEAN UROLOGY (2012)
Spread of OnabotulinumtoxinA After Bladder Injection. Experimental Study Using the Distribution of Cleaved SNAP-25 as the Marker of the Toxin Action
Ana Coelho et al.
EUROPEAN UROLOGY (2012)
997 Urinary levels of noradrenaline are increased in patients with bladder pain syndrome/interstitial cystitis and are decreased by intratrigonal onabotulinum toxin type A injection
R.M.C.A. Pinto et al.
EUROPEAN UROLOGY SUPPLEMENTS (2012)
Effect of OnabotulinumtoxinA on Intramural Parasympathetic Ganglia: An Experimental Study in the Guinea Pig Bladder
Ana Coelho et al.
JOURNAL OF UROLOGY (2012)
Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay
Ester Fernandez-Salas et al.
PLOS ONE (2012)
Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type a injection
Tiago Gorgal et al.
BMC UROLOGY (2012)
Intraprostatic botulinum toxin type A administration: evaluation of the effects on sexual function
Joao Silva et al.
BJU INTERNATIONAL (2011)
Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial
Francisco Cruz et al.
EUROPEAN UROLOGY (2011)
Effects of 100 and 300 Units of Onabotulinum Toxin A on Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Phase II Randomized Clinical Trial
E. David Crawford et al.
JOURNAL OF UROLOGY (2011)
Intravesical Electromotive Botulinum Toxin Type A Administration-Part II: Clinical Application
Abdol-Mohammad Kajbafzadeh et al.
UROLOGY (2011)
In the Human Urothelium and Suburothelium, Intradetrusor Botulinum Neurotoxin Type A Does Not Induce Apoptosis: Preliminary Results
Thomas M. Kessler et al.
EUROPEAN UROLOGY (2010)
Trigonal Injection of Botulinum Toxin A in Patients with Refractory Bladder Pain Syndrome/Interstitial Cystitis
Rui Pinto et al.
EUROPEAN UROLOGY (2010)
Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder
Ana Coelho et al.
EUROPEAN UROLOGY (2010)
Immunohistochemical Expression of Muscarinic Receptors in the Urothelium and Suburothelium of Neurogenic and Idiopathic Overactive Human Bladders, and Changes With Botulinum Neurotoxin Administration
Soumendra N. Datta et al.
JOURNAL OF UROLOGY (2010)
Interstitial Cells in the Urinary Bladder-Localization and Function
Karen D. McCloskey
NEUROUROLOGY AND URODYNAMICS (2010)
Subcutaneous Injection of Botulinum Toxin A Is Beneficial in Postherpetic Neuralgia
Lizu Xiao et al.
PAIN MEDICINE (2010)
Lack of effectiveness of botulinum neurotoxin A on isolated detrusor strips and whole bladders from mice and guinea-pigs in vitro
Sarah Howles et al.
BJU INTERNATIONAL (2009)
Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome
Hann-Chorng Kuo et al.
BJU INTERNATIONAL (2009)
Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment
Alexander Roosen et al.
EUROPEAN UROLOGY (2009)
Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection
Hsin-Tzu Liu et al.
EUROPEAN UROLOGY (2009)
Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report
Apostolos Apostolidis et al.
EUROPEAN UROLOGY (2009)
Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat
Joao Silva et al.
EUROPEAN UROLOGY (2009)
Urodynamic and Immunohistochemical Evaluation of Intravesical Botulinum Toxin A Delivery Using Liposomes
Yao-Chi Chuang et al.
JOURNAL OF UROLOGY (2009)
A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging
Ulrich Mehnert et al.
WORLD JOURNAL OF UROLOGY (2009)
Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury
Christopher P. Smith et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Effects of the m3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve
Kazuyoshi Iijima et al.
EUROPEAN UROLOGY (2007)
Effects of botulinurn toxin A on the contractile function of dog prostate
Alex Tong Long Lin et al.
EUROPEAN UROLOGY (2007)
Mechanisms of Disease: involvement of the urothelium in bladder dysfunction
Lori A. Birder et al.
NATURE CLINICAL PRACTICE UROLOGY (2007)
Histologic features in the urinary bladder wall affected from neurogenic overactivity -: A comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A
Eva Comperat et al.
EUROPEAN UROLOGY (2006)
A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4
Joseph W. Arndt et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
SV2 is the protein receptor for botulinum neurotoxin A
M Dong et al.
SCIENCE (2006)
Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity
A Apostolidis et al.
EUROPEAN UROLOGY (2006)
Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study
A Giannantoni et al.
EUROPEAN UROLOGY (2006)
Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder
DE Rapp et al.
JOURNAL OF UROLOGY (2006)
Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates
YC Chuang et al.
UROLOGY (2005)
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity
A Apostolidis et al.
JOURNAL OF UROLOGY (2005)
Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: Effect of botulinum toxin A
CP Smith et al.
NEUROCHEMISTRY INTERNATIONAL (2005)
Localized contractions in the normal human bladder and in urinary urgency
MJ Drake et al.
BJU INTERNATIONAL (2005)
Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation
VM Vemulakonda et al.
JOURNAL OF UROLOGY (2005)
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralizaiion
TJ Smith et al.
INFECTION AND IMMUNITY (2005)
P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin
CM Brady et al.
EUROPEAN UROLOGY (2004)
Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury
M Khera et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Urinary bladder contraction and relaxation: Physiology and pathophysiology
KE Andersson et al.
PHYSIOLOGICAL REVIEWS (2004)
Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity
C Morenilla-Palao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: Results of a randomized, placebo-controlled study
G Maria et al.
UROLOGY (2003)
Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract
CP Smith et al.
JOURNAL OF UROLOGY (2003)
The role of the human bladder lamina propria myofibroblast
OJ Wiseman et al.
BJU INTERNATIONAL (2003)
Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin
MJ Duggan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
P2X receptors and their role in female idiopathic detrusor instability
BA O'Reilly et al.
JOURNAL OF UROLOGY (2002)
Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells
LA Birder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice
DA Cockayne et al.
NATURE (2000)
Intravesical oxyhemoglobin initiates bladder overactivity in conscious, normal rats
RK Pandita et al.
JOURNAL OF UROLOGY (2000)
Treatment of neurogenic incontinence with botulinum toxin A.
B Schurch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
How botulinum and tetanus neurotoxins block neurotransmitter release
Y Humeau et al.
BIOCHIMIE (2000)
Share Paper
